Reducing neonatal Fc receptor binding enhances clearance and brain-to-blood ratio of TfR-delivered bispecific amyloid-β antibody
Recent development of amyloid-β (Aβ)-targeted immunotherapies for Alzheimer’s disease (AD) have highlighted the need for accurate diagnostic methods. Antibody-based positron emission tomography (PET) ligands are well suited for this purpose as they can be directed toward the same target as the thera...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis Group
2024-12-01
|
| Reeks: | mAbs |
| Onderwerpen: | |
| Online toegang: | https://www.tandfonline.com/doi/10.1080/19420862.2024.2339337 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|